GlassScriptPhysician profile
Raymond Chow
NPI 1356369037
$15,463.04
in general payments reported to CMS, 2019-2025
52 companies · $1,867 in 2025
The $1,867 reported for 2025 was more than what 93% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,615 · 2020: $2,217 · 2021: $2,142 · 2022: $2,370 · 2023: $2,546 · 2024: $1,705 · 2025: $1,867.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,054 · Education: $63.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,054.37 |
| Education | $63.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $2,740.34 | 2019-2025 | Xarelto, Opsumit, Uptravi |
| E.R. Squibb & Sons, L.L.C. | $1,855.86 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $1,384.75 | 2019-2025 | |
| Pfizer INC. | $986.80 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $917.83 | 2019-2025 | Jardiance |
| Abbott Laboratories | $830.14 | 2019-2025 | Cardiomems, Aveir, Mitraclip |
| Amgen INC. | $788.93 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $657.94 | 2019-2025 | Watchman Flx, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $632.12 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Esperion Therapeutics, INC. | $384.46 | 2020-2025 | Nexletol |
| Abiomed | $334.25 | 2022-2025 | Impella |
| Alnylam Pharmaceuticals INC. | $326.89 | 2022-2023 | Onpattro |
| Novo Nordisk INC | $292.68 | 2019-2024 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $282.89 | 2022-2025 | Verquvo |
| Bayer Healthcare Pharmaceuticals INC. | $253.70 | 2022-2025 |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Preventric Diagnostics, INC. | $250.24 | 2021 | |
| Lundbeck LLC | $238.79 | 2019-2021 | |
| Scpharmaceuticals INC. | $211.74 | 2024-2025 | |
| Sanofi-Aventis U.S. LLC | $194.11 | 2019-2024 | |
| Impulse Dynamics (USA) INC. | $191.88 | 2022-2023 | Optimizer |
| Edwards Lifesciences Corporation | $170.33 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Heartflow, INC. | $162.52 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $116.90 | 2020-2023 | Uptravi, Opsumit |
| Arbor Pharmaceuticals, INC. | $95.27 | 2020-2021 | |
| Inspire Medical Systems, INC. | $90.50 | 2023-2024 | Inspire |
| Lexicon Pharmaceuticals, INC. | $87.96 | 2023 | Inpefa |
| Kowa Pharmaceuticals America, INC. | $85.13 | 2019-2020 | |
| Akcea Therapeutics, INC. | $84.47 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $82.70 | 2019-2022 | |
| Azurity Pharmaceuticals, INC. | $70.62 | 2023-2024 | Edarbi, Edarbyclor |
| Medtronic, INC. | $70.05 | 2021-2025 | Linq II, Venaseal |
| Astellas Pharma US INC | $57.39 | 2019-2023 | Lexiscan |
| Kiniksa Pharmaceuticals, LTD. | $53.64 | 2021-2023 | Arcalyst |
| Medtronic Vascular, INC. | $48.20 | 2019 | |
| Daiichi Sankyo INC. | $45.45 | 2022-2024 | Injectafer |
| Philips North America LLC | $43.49 | 2021-2022 | |
| Corcept Therapeutics | $36.13 | 2025 | Korlym |
| Kiniksa Pharmaceuticals International, Plc | $30.18 | 2024 | Arcalyst |
| Allergan, INC. | $28.29 | 2019 | |
| Terumo Medical Corporation | $27.59 | 2019 | |
| Csl Behring | $27.01 | 2023 | Kcentra |
| Cardiva Medical, INC. | $26.06 | 2023 | Cardiva Vascade 6/7f Vcs |
| Baxter Healthcare | $24.06 | 2023 | Biopharma Sol - Contract Manuf |
| Lantheus Medical Imaging, INC. | $20.05 | 2019 | |
| Biocompatibles, INC. | $19.03 | 2019 | |
| Cordis US Corp. | $18.74 | 2025 | Mynx Control Venous |
| Bridgebio Pharma, INC. | $17.30 | 2025 | Attruby |
| Glaxosmithkline, LLC. | $16.23 | 2025 | Shingrix, Arexvy |
| Veryan Medical Incorporated | $14.90 | 2021 | |
| Idorsia Pharmaceuticals US INC | $13.50 | 2025 | Tryvio |
| Bard Peripheral Vascular, INC. | $13.01 | 2023 | Venclose Maven Catheter |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymond Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.